BJA FY 21 Harold Rogers Prescription Drug Monitoring Program (PDMP) | O BJA 2021 49001

Opportunity Information: Apply for O BJA 2021 49001

The BJA FY 21 Harold Rogers Prescription Drug Monitoring Program (PDMP) grant is a discretionary funding opportunity from the U.S. Department of Justice, Bureau of Justice Assistance (BJA), designed to strengthen how jurisdictions track and analyze prescriptions for controlled substances (and certain other scheduled chemical products). The central idea is to support a centralized PDMP database run by an authorized agency so that prescription data can be collected in a consistent way and then used by regulatory bodies, law enforcement, and public health officials to identify trends, detect suspicious prescribing or dispensing patterns, and inform interventions that reduce misuse and diversion while supporting legitimate medical use.

This program is focused on building or improving the capacity of PDMP systems and the surrounding operational ecosystem that makes them useful. In practical terms, that typically means improving the ability to receive timely prescription submissions, maintain high-quality and usable data, and provide appropriate access and analytical tools to the agencies and officials who are authorized to use the information. The emphasis on both analysis and multi-sector use (regulatory, law enforcement, and public health) signals that BJA is supporting PDMPs not just as data warehouses, but as operational tools that help jurisdictions understand and respond to controlled-substance risks and patterns.

Eligibility is primarily aimed at state-level and territorial governments that already have, or are in the process of establishing, an enabling statute or regulation that requires the submission of controlled substance prescription data to an authorized state agency. The solicitation also creates a pathway for local or regional applicants in states that do not yet have a qualifying statewide enabling law. In that situation, a city, county, or region may apply if it meets three conditions: first, it must have enacted its own enabling statute, ordinance, or regulation requiring prescription data submission to an authorized local or regional agency; second, it must agree to transfer the PDMP system to an authorized state agency if the state later adopts an enabling statute requiring statewide reporting to a state agency; and third, it must ensure all vendor contracts are written so that ownership of the PDMP system can be transferred to the state agency. Those conditions are meant to prevent fragmentation and protect long-term continuity by making sure a locally built system can be smoothly integrated into a future statewide PDMP framework.

From the funding details provided, this opportunity is identified as "BJA FY 21 Harold Rogers Prescription Drug Monitoring Program (PDMP)" with Funding Opportunity Number O-BJA-2021-49001. It is offered as a grant under the Affordable Care Act funding activity category and is associated with CFDA number 16.754. Eligible applicant types listed include state governments, U.S. territories, county governments, city or township governments, and other entities as allowed under the solicitation’s eligibility rules. The original application closing date was March 19, 2021, and the opportunity was created on December 21, 2020. The maximum award amount (award ceiling) listed is $1,500,000. The notice also indicates that awards were expected, though the exact number is not specified in the excerpt.

Overall, the grant opportunity is best understood as federal support to help jurisdictions develop or enhance the legal, technical, and operational capacity to run a PDMP that reliably captures controlled substance prescription data in a centralized system and turns that information into actionable insight for appropriate government and public health use. The eligibility structure also reflects an effort to keep PDMP development scalable and transferable, especially in places where statewide statutory authority may not yet be in place.

• The Bureau of Justice Assistance in the affordable care act sector is offering a public funding opportunity titled "BJA FY 21 Harold Rogers Prescription Drug Monitoring Program (PDMP)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 16.754.
• This funding opportunity was created on 2020-12-21.
• Applicants must submit their applications by 2021-03-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Others.

Apply for O BJA 2021 49001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: